Thor G Theander

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Low Density Lipoprotein

Plasmodium Falciparum

Toxoplasma Gondii

Biofilm Formation

Top Venues

bioRxiv : the preprint server for biology

This page only lists publications with an associated author ORCID identifier.

Publications

Raphael A Reyes, Sai Sundar Rajan Raghavan, Nicholas K Hurlburt, Viola Introini, Ikhlaq Hussain Kana, Rasmus W Jensen, Elizabeth Martinez-Scholze, Maria Gestal-Mato, Cristina Bancells Bau, Monica Lisa Fernández-Quintero, Johannes R Loeffler, James Alexander Ferguson, Wen-Hsin Lee, Greg Michael Martin, Thor G Theander, Isaac Ssewanyana, Margaret E Feeney, Bryan Greenhouse, Sebastiaan Bol, Andrew B Ward, Maria Bernabeu, Marie Pancera, Louise Turner, Evelien M Bunnik, Thomas Lavstsen
Broadly inhibitory antibodies against severe malaria virulence proteins. bioRxiv : the preprint server for biology (2024)
Raphael A Reyes, Sai Sundar Rajan Raghavan, Nicholas K Hurlburt, Viola Introini, Ikhlaq Hussain Kana, Rasmus W Jensen, Elizabeth Martinez-Scholze, Maria Gestal-Mato, Cristina Bancells Bau, Monica Lisa Fernández-Quintero, Johannes R Loeffler, James Alexander Ferguson, Wen-Hsin Lee, Greg Michael Martin, Thor G Theander, Isaac Ssewanyana, Margaret E Feeney, Bryan Greenhouse, Sebastiaan Bol, Andrew B Ward, Maria Bernabeu, Marie Pancera, Louise Turner, Evelien M Bunnik, Thomas Lavstsen
Broadly inhibitory antibodies against severe malaria virulence proteins. bioRxiv : the preprint server for biology (2024)
Louise Goksøyr, Magdalena Skrzypczak, Maureen Sampson, Morten Agertoug Nielsen, Ali Salanti, Thor G Theander, Alan T Remaley, Willem A De Jongh, Adam Frederik Sander
A cVLP-Based Vaccine Displaying Full-Length PCSK9 Elicits a Higher Reduction in Plasma PCSK9 Than Similar Peptide-Based cVLP Vaccines. Vaccines 11 (1) (2022)
Louise Goksøyr, Magdalena Skrzypczak, Maureen Sampson, Morten Agertoug Nielsen, Ali Salanti, Thor G Theander, Alan T Remaley, Willem A De Jongh, Adam Frederik Sander
A cVLP-Based Vaccine Displaying Full-Length PCSK9 Elicits a Higher Reduction in Plasma PCSK9 Than Similar Peptide-Based cVLP Vaccines. Vaccines 11 (1) (2022)
Louise Goksøyr, Magdalena Skrzypczak, Maureen Sampson, Morten Agertoug Nielsen, Ali Salanti, Thor G Theander, Alan T Remaley, Willem A De Jongh, Adam Frederik Sander
A cVLP-Based Vaccine Displaying Full-Length PCSK9 Elicits a Higher Reduction in Plasma PCSK9 Than Similar Peptide-Based cVLP Vaccines. Vaccines 11 (1) (2022)
Louise Goksøyr, Magdalena Skrzypczak, Maureen Sampson, Morten Agertoug Nielsen, Ali Salanti, Thor G Theander, Alan T Remaley, Willem A De Jongh, Adam Frederik Sander
A cVLP-Based Vaccine Displaying Full-Length PCSK9 Elicits a Higher Reduction in Plasma PCSK9 Than Similar Peptide-Based cVLP Vaccines. Vaccines 11 (1) (2022)